Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (49)

« Back to Publications

Proteomic Signatures of Neuropathological Alterations in Alzheimer’s Disease: Insights from the Bio-Hermes Study

Zhao H. et al, (2026)

Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition.

Clos-Garcia M. et al, (2026), medRxiv

An Explainable Deep Learning Framework for Imaging Genetics: Deriving Brain-Genotype Scores From MRI to Link Genetic Variation, Brain Structure, and Cognition

Alhasani KT. et al, (2026)

Establishing a relationship between iron-based blood measures and structural brain changes using neural networks in UK Biobank.

Sammet J. et al, (2026), Med Image Anal, 111

Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology.

Finney CA. et al, (2025), bioRxiv

Phosphodiesterase-5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study.

Alcalde-Herraiz M. et al, (2025), Aging Cell, 24

Biomarkers.

Ali M. et al, (2025), Alzheimers Dement, 21 Suppl 2

Cognition and Future Depression: Associations with Risk in Those With and Without a History of Depression

de Cates AN. et al, (2025)

The relationship between anaemia, haemoglobin levels, and cognitive function: Evidence in two population-based cohorts from India and the United States.

Winchester LM. et al, (2025), Neurobiol Dis, 216

Interplay between age, APOE Ɛ4 and the metabolome in plasma and brain in Alzheimer's disease.

Amin N. et al, (2025), Transl Psychiatry, 15

Author Correction: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

Ali M. et al, (2025), Nat Med, 31

APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseases.

Shvetcov A. et al, (2025), Nat Med, 31, 2590 - 2601

The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.

Imam F. et al, (2025), Nat Med, 31, 2556 - 2566

Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

Ali M. et al, (2025), Nat Med, 31, 2567 - 2577

Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders.

Homann J. et al, (2025)

Load More